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To the Editor,
We read with great interest the recent report in the Journal of Dumas and colleagues 
summarizing extensive data on ventilation strategies in immunocompromised patients with 
acute respiratory failure (ARF) (1). The authors concluded that delayed intubation might be 
independently associated with increased mortality in immunocompromised patients. 
Pickkers and van Haren challenged this conclusion in their thoughtful editorial by 
emphasizing several important limitations of the study, including incomplete available data 
from all included studies and the overall small number of randomized studies conferring the 
risk of several confounding issues (2). The most important limitation is based on the fact that 
all non-invasively ventilated patients included in this meta-analysis were eventually 
intubated, not allowing any robust statements about inferiority of non-invasive techniques per 
se. 
We agree with our colleagues that this introduces a strong selection bias, as patients 
who will eventually fail non-invasive ventilation (NIV) might differ in many characteristics 
from those that might be successfully bridged with a NIV strategy. Bearing in mind the 
exceedingly high mortality of immunocompromised patients requiring invasive mechanical 
ventilation (1), we believe it would be premature to advise towards a general rule of early 
intubation in all of these patients. 
Ventilator induced lung injury, ventilator acquired pneumonia and ventilator induced 
diaphragm dysfunction are well-known side effects of invasive ventilation and may 
contribute to and aggravate the complex pathophysiology of multi-organ failure and death in 
ARF (3). The use of extracorporeal membrane oxygenation (ECMO) in non-intubated 
patients who are awake and spontaneously breathing (termed awake ECMO) might 
theoretically avoid side effects and complications associated with sedation, intubation, and 
Page 2 of 4
 AJRCCM Articles in Press. Published June 17, 2021 as 10.1164/rccm.202105-1160LE 
 Copyright © 2021 by the American Thoracic Society 
invasive mechanical ventilation (4). We recently described our single-center experience with 
a primary awake ECMO strategy in 18 non-intubated immunocompromised patients with 
severe acute respiratory distress syndrome (ARDS) (median PaO2/FiO2 72 (65-82)) who 
presented without secondary organ dysfunction (5). During their ICU stay, 11 patients (61%) 
required secondary intubation. Of note, the most common reason for secondary intubation 
was severe agitation. In-hospital mortality was 73% in patients who required secondary 
intubation versus 14% in patients who did not require intubation while on ECMO support 
(Hazard Ratio: 0.133 (0.058 – 0.789; p=0.023). 
Although limited by the small sample size and the uncontrolled nature of the study, 
we believe that these data demonstrate as a proof of principle that in selected 
immunocompromised patients with ARDS, an awake ECMO strategy may be used to avoid 
intubation and mechanical ventilation. Of course, further data is needed, but the high 
mortality of immunocompromised patients who require mechanical ventilation warrants the 
exploration of alternative strategies.   
A patient individualized approach considering all available options and continuously 
weighing the benefits of avoiding the well-known side effects of invasive ventilation while 
not ignoring the risks of patient self inflicted lung injury (P-SILI) (6) provoked by delaying 
intubation for too long, clearly will be critical on our path towards improving the care of 
immunocompromised patients with ARF. 
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